- Trinity Health to open $226M replacement hospital April 19
- Sharp HealthCare taps Apple Vision Pro for surgical innovation
- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- 10 fastest-growing jobs for new graduates
- Northwestern Medicine posts 4.5% operating margin in Q2
- Rotavirus cases increase across US
- Tenet’s 5 highest-paid execs in 2025
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- 10 trends in behavioral health usage: Report
- How hospitals are winning — and losing — the ASC moment
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- Former Utah dentist accused of practicing dentistry without a license
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The new playbook for clinician well-being
- Listen to the Latest ‘KFF Health News Minute’
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
There have been leadership changes announced at several U.S. Department of Health and Human Services (HHS) agencies:
https://thehill.com/policy/healthcare/5744237-kennedy-reshapes-hhs-leadership/
NIH director Bhattacharya to temporarily serve as CDC director
By Sophie Brams - February 18, 2026Director of the National Institutes of Health Jay Bhattacharya will serve as interim director of the Centers for Disease Control and Prevention (CDC) following the reported exit of Jim O’Neill, a Trump administration official confirmed Wednesday.
It was reported last week that O’Neill, who also served as deputy secretary of the Department of Health and Human Services (HHS), would be leaving his post as part of a broader staff restructuring within the department.
O’Neill is expected to be nominated by President Trump to lead the National Science Foundation, according to The New York Times, which first reported the news of Bhattacharya’s new role.
The shake-up at HHS comes as the Trump administration is sharpening its message on health care ahead of the midterms, hoping Secretary Robert F Kennedy Jr.’s efforts to reshape federal health policy over the past year will resonate with voters and help deliver Republican wins come November.
Other leadership shifts include Centers for Medicare and Medicaid Services (CMS) Deputy Administrator Chris Klomp taking on the role of chief counselor at HHS, and John Brooks transitioning from CMS deputy administrator and chief policy and regulatory officer to CMS senior counselor.
At the Food and Drug Administration (FDA), Deputy Commissioners Kyle Diamantas and Grace Graham were also given new posts as senior counselors.
“In just over a year, we have driven historic progress on President Trump’s health care priorities and delivered real, measurable change,” Kennedy said in a Feb. 12 statement announcing the changes.
“We are restoring accountability, challenging entrenched interests, and putting the health of the American people first. I am proud to elevate battle-tested, principled leaders onto my immediate team—individuals with the courage and experience to help us move faster and go further as we work to Make America Healthy Again,” he added.
The CDC itself has seen abrupt leadership changes over the past year, including the ouster of Director Susan Monarez last August, who was fired less than a month into the job after she refused pressure from the White House to resign.
Bhattacharya, a Stanford University professor, is now poised to take the helm at a time when the agency has come under scrutiny for its shifts to vaccination policies and recommendations.
He said during a Senate hearing last week that he had not seen any studies supporting a potential connection between any vaccine and autism, disputing a theory often peddled by Kennedy.
Bhattacharya is slated to serve as interim director until the U.S. Senate confirms a permanent successor.
After falsely savaging Dr. Jay Bhattacharya during the pandemic, the health care Deep State is now terrified of him:
https://thehill.com/policy/healthcare/5748218-bhattacharya-cdc-nih-leadership-concern/
Bhattacharya’s growing power in Trump’s HHS worries health experts
By Joseph Choi - February 22, 2026Public health experts and former federal staffers are uneasy over National Institutes of Health (NIH) Director Jay Bhattacharya’s rising influence over U.S. health policy as he temporarily takes on the added role of leading the Centers for Disease Control and Prevention (CDC).
The Trump administration announced the leadership shake-up this week, with former interim CDC Director Jim O’Neill being moved out of the Department of Health and Human Services (HHS).
“Candidly, this is someone who very clearly has an ax to grind with science and the scientific community in general,” Kayla Hancock, director of Protect our Care’s Public Health Watch project, said of Bhattacharya.
“We’ve seen with his record already at NIH and his history of Covid denialism before he even took this office that this is just not the kind of person that we need at the helm of our key public health and medical research institutions.”
Bhattacharya, confirmed as NIH director in March of last year, was a Stanford University professor of medicine before joining the Trump administration. He was also one of the lead authors of “Great Barrington Declaration,” a 2020 open letter calling for COVID-19 lockdowns to be rolled back.
In an email to CDC staff on Friday, Bhattacharya laid out what he said was a plan to restore trust in public health. During the pandemic, he wrote, it was “undeniable that some of the Federal government’s decisions, communications, and processes contributed to confusion, frustration, and a loss of that trust.”
“I also recognize the unique challenges faced by each of you over the past year due to abrupt changes in leadership, the tragic act of violence last summer, and overall uncertainty felt by all of you,” wrote Bhattacharya, referring to the fatal shooting at the CDC’s headquarters last year. “One of my goals is to ensure that you all get the recognition you deserve for your efforts.”
He listed three principles the agency would follow under his rule: updating guidance “transparently” as new data emerges, ensuring every investigation it conducts reflects the “responsibility to the communities we serve” and strengthening internal review processes to enhance “accountability and openness.”
The position of CDC director has been haphazardly filled over the past year. President Trump’s first pick, former Florida Rep. David Weldon (R), failed to gain support in the Senate, leading to longtime federal scientist Susan Monarez, the interim director, receiving the nomination to fill the role permanently.
Monarez was ultimately confirmed by the Senate along party lines, but only weeks later the administration pushed her out, with her claiming it was due to her refusal to give blanket approval of recommendations from the CDC’s Advisory Committee on Immunization Practices, which Health and Human Services Secretary Robert F. Kennedy Jr. had restaffed with ideological allies.
O’Neill, a deputy HHS secretary, was then made the interim director, making Bhattacharya the third acting CDC director in seven months.
Former CDC physician Elizabeth Soda, who resigned late last year, said the American public is suffering because of the lack of stable leadership within the agency.
She noted how Congress had largely maintained funding for the agency, rejecting calls by the administration to deeply cut appropriations, indicating the legislative branch recognizes the importance of a strong CDC.
“How can you even do the work that they’re being given the money to do, right? That’s a big challenge, and without having clear leadership, who can really devote the time and energy and expertise to face these challenges head on?” Soda said.
Former federal staffers and public health voices who spoke with The Hill said the NIH and CDC agencies are too large and distinct from one another to have one individual leading both at the same time.
“I don’t think Jay Bhattacharya can be trusted to lead either. But I think the size of both of these organizations and the missions are different, and I think it takes a specific type of person, a single person, to do each of these jobs,” said James Alwine, coordinating committee member of the nonprofit volunteer network Defend Public Health and professor emeritus of cancer biology at the University of Pennsylvania School of Medicine.
The NIH’s primary objective is to support U.S. research infrastructure, while the CDC is largely tasked with surveilling and addressing disease threats.
Alwine began his career at the NIH. He opined that Bhattacharya’s motivations to lead these agencies did not align with their missions of promoting and protecting public health.
“I think some of the things he’s doing certainly look to me like he’s getting back at those who came down on him because they criticized him so much about the Great Barrington Resolution,” Alwine said.
When reached for comment, HHS spokesperson Emily Hilliard said of Bhattacharya, “The Director has empowered the NIH leadership team to ensure the agency’s priorities continue moving forward until the President nominates and the Senate confirms a permanent CDC director.”
“CDC Principal Deputy Director Ralph Abraham and other members of the CDC leadership team will work closely with Dr. Bhattacharya during this acting period to continue protecting and serving the American people,” Hilliard added. “The Director is solely focused on ensuring a seamless transition for both agencies while maintaining continuity of leadership and advancing their core public health missions.”
Monarez, the only confirmed CDC director in Trump’s second term, was an outlier when it came to health nominees. She did not come from the “Make America Healthy Again” (MAHA) antiestablishment world that many of Kennedy’s picks came from, having been a government scientist for decades.
Her refusal to bend completely to the MAHA agenda seemingly played a significant part in her termination.
With Bhattacharya’s temporary dual role, public health influence has become further consolidated among ardent Kennedy allies. Whether Trump and Kennedy can find a MAHA ally who can also win Senate confirmation as CDC director remains to be seen.
Soda, the former CDC staffer, was hopeful that compromises could be made for the sake of stable leadership at the agency.
“The optimist in me can hope,” Soda said. “We have to come to some middle ground understanding with one another, where we may not fully agree completely. But wouldn’t it be great if we could try to start moving towards the middle.”
“In some ways, MAHA’s beliefs, I think, are just so contrary to what CDC represents,” Soda added. “It would be difficult, I think, to find someone who’s a true sort of believer in those principles to also then come and successfully lead the agency that is, you know, the agency that is driven by scientific evidence and data.”
😎 Coming to a theater near you: Jay Bhattacharya, the movie!
https://www.politico.com/news/2026/02/22/the-next-hollywood-hero-jay-bhattacharya-00791313
RFK Jr.’s billionaire running mate is making a comedy about the pandemic
Nicole Shanahan has recruited a top screenwriter and enlisted Covid contrarian Jay Bhattacharya.
By Kelly Hooper - February 22, 2026Covid contrarians tight with Robert F. Kennedy Jr. are pitching Hollywood on an unlikely leading man: National Institutes of Health Director Jay Bhattacharya.
Nicole Shanahan, Kennedy’s running mate in the 2024 presidential campaign, is searching for investors to fund a movie that pokes fun at the pandemic response with a star based on Bhattacharya, who rose to prominence with his anti-lockdown manifesto and relentless tweets opposing social distancing.
The script for the satirical comedy, “The Rash,” is by renowned author Walter Kirn, who wrote the novel “Up in the Air” that became an Oscar-nominated movie starring George Clooney. The new Kirn screenplay stars a “no-nonsense” public health professor at a Stanford-like California university — mirroring Bhattacharya — who speaks out against mass hysteria amid a mysterious outbreak of a contagious skin condition.
The story of the pandemic is one “of great heroes who stood up and said no” to “dangerous scientific experiments mixed with misleading propaganda, mass psychosis, and outright lies,” says the Brownstone Institute in a recent appeal sent to potential funders of the film.
The think tank that once counted Bhattacharya as a senior scholar added that “investors are terrified of the topic and Hollywood elites don’t even want it made.”
The push to make the film is among numerous examples, since President Donald Trump returned to office, in which the president or his allies have sought approbation from America’s culture-making institutions. They’ve had some success. Trump allies renamed the Kennedy Center in Washington to honor him in December and Amazon released a film last month about first lady Melania Trump.
Since 2020, a number of figures in Trump’s orbit have been involved in the creation and promotion of films criticizing public officials’ response to the pandemic or pushing fringe theories about it or vaccines.
Jeffrey Tucker, Brownstone’s founder and president, didn’t respond to requests for comment. In October 2020, he convened a group of scientists, including Bhattacharya, who wrote the Great Barrington Declaration opposing Covid lockdowns. It set off a vigorous debate about the pandemic response and prompted Bhattacharya’s predecessor at NIH, Francis Collins, to call him a “fringe epidemiologist.”
Bhattacharya, whom Kennedy also named acting director of the Centers for Disease Control and Prevention on Wednesday, is on board with the movie, an NIH spokesperson told POLITICO.
“Dr. Bhattacharya has spoken positively about the work Walter Kirn is doing, noting that the project reflects a strong commitment to free speech and open inquiry, and he welcomes thoughtful creative efforts that engage with these issues,” the spokesperson said.
Bhattacharya declined to comment. He’s spent at least 10 hours speaking to Kirn, who shares his views on the handling of the pandemic, for the film.
Shanahan is an executive producer of “The Rash” along with her partner, Jacob Strumwasser, according to Brownstone. Neither Shanahan nor Strumwasser could be reached for comment. Shanahan, a lawyer and entrepreneur, is reportedly a billionaire following her divorce three years ago from Google founder Sergey Brin. While married to Brin, she founded a philanthropy that focuses on extending women’s fertility.
Funding for “The Rash” nonetheless remains an obstacle. The estimated production budget is close to $6 million, according to a slide deck on Brownstone’s website.
Brownstone “is well-positioned to be a fiscal sponsor of this effort,” and the project “already has a top production company lined up along with some notable talent to make a first-rate film,” the website says.
In September, Kirn released a short teaser trailer for “The Rash” on social platform X, saying the film is in the financing phase and interested investors should contact him.
Kirn did not respond to a request for comment.
He said in the X post that he wrote the film for Shanahan and 0nset Creative, an independent production company founded by Alex Lee Moyer, a filmmaker whose credits include a 2022 documentary on far-right conspiracy theorist Alex Jones. In September, as a guest on Shanahan’s podcast, Moyer described the Jones documentary as a film about Covid, the “runway to Jan. 6” and “how off the rails the world went during that moment.”
Three pages of the script for “The Rash” are previewed on Brownstone’s website. In one scene, the governor of California and a character named Dr. Roman Fox orchestrate a celebrity singalong amid the outbreak. A “succession of celebs sing lines from the song ‘Aquarius’ by the Fifth Dimension,” the script reads.
“Some sing beautifully, some not,” the screenplay says. “Behind them are their yards and homes. One sings naked with his crotch blurred out, his body gleaming with oil.”
The song, a No. 1 hit in 1969 based on numbers from the musical Hair, previews a time when Jupiter aligns with Mars and “peace will guide the planets and love will steer the stars.”
The scene appears to poke fun at a celebrity singalong of the John Lennon song “Imagine” during the early days of the Covid pandemic, spearheaded by actress Gal Gadot. At the time, the viral video was widely criticized as elitist and out of touch.
0nset Creative was “established in response to a landscape where media has become decentralized and old models are buckling under the weight of the times,” its website says. The studio is working on a handful of other projects in addition to “The Rash,” including “the first in depth documentary about Silicon Valley and its denizens” and another documentary on unidentified flying objects.
During the September podcast interview with Moyer, Shanahan said she and her partner, Strumwasser, had the “stupid idea” for a satire film inspired by the Covid pandemic and decided to run with it.
“We were like, ‘Wouldn’t it be great if we could just laugh about how ridiculous this all was and how awful it all was?’ But also laugh at it because that means that it’s in the past,” she said.
Moyer said Shanahan approached 0nset Creative with the idea.
“I got to thinking, ‘Well, who’s the best person who can work on this? Who can write a script that’s worthy of this topic?’ And I thought of my good friend, Walter Kirn,” said Moyer.
Shanahan and Strumwasser gave Kirn creative liberty to tell the story in the way he wanted, and he came back with the script for “The Rash,” Moyer added.
Moyer said “The Rash” reminds her of conspiracy thrillers from the ‘60s and ‘70s like “Dr. Strangelove” and “Network,” as well as “some of the lighter influences from films in the ‘90s” like “Wag the Dog” and “Thank You for Smoking.”
“We need to be able to have a sense of humor about our collective trauma,” Moyer told Shanahan.
0nset Creative did not respond to a request for comment, and Moyer could not be reached.
A second scene in the script features a conversation between Fox and “Dr. Neal Chandra,” the character based on Bhattacharya. Fox declares “I’m the science” during the scene — an apparent reference to a 2021 interview in which Anthony Fauci, who led the U.S. pandemic response, said his critics were “really criticizing science because I represent science.” Fox encourages Chandra to sign a document supporting that statement. Chandra refuses.
In a description of the film’s cinematography, the slide deck on Brownstone’s website says the movie will “toggle between composed shots that reflect Dr. Chandra’s rational perspective and looser, handheld coverage that captures the surrounding chaos: influencers melting down on livestreams, press conferences spinning off-script, executives high on their own power.”
“The world bends while Chandra stands still,” the description reads.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















